https://www.profitablecpmrate.com/nsirjwzb79?key=c706907e420c1171a8852e02ab2e6ea4
Skip to content 
CooperCompanies (NYSE: COO) has reported an increase in revenues and adjusted earnings for the fourth quarter of fiscal 2025. The medical device maker also issued guidance for the first quarter and fiscal 2026. Cooper’s fourth-quarter 2025 revenue increased 5% year-over-year to $1.07 billion; it was up 3% organically On a reported basis, Q4 earnings declined … Read more
Medical device maker CooperCompanies (NYSE: COO) has reported a double-digit increase in adjusted earnings for the third quarter of 2025 amid strong sales growth. Third-quarter revenue increased 6% year-over-year to $1.06 billion; CooperVision revenue rose 6% to $718.4 million At $341.9 million, revenues of the CooperSurgical (CSI) business division were up 4% On an adjusted … Read more
Medical device maker CooperCompanies (NYSE: COO) has reported an increase in adjusted earnings for the second quarter of 2025, aided by a 6% revenue growth. CooperComapanies second-quarter revenue increased 6% year-over-year to $1.0 billion, up 7% in constant currency CooperVision revenue rose 5% to $669.6 million in Q2; CooperSurgical revenue moved up 8% to $332.7 … Read more
Medical device maker CooperCompanies (NYSE: COO) has announced financial results for the first quarter of 2025, reporting an increase in revenues and adjusted profit. First-quarter revenue increased 4% year-over-year to $964. 7 million; CooperVision and CooperSurgical revenues grew 4% and 3%, respectively On a reported basis, earnings per share was $0.52 in Q1, up 27% … Read more
https://www.profitablecpmrate.com/nsirjwzb79?key=c706907e420c1171a8852e02ab2e6ea4